Improving Time to Treatment Initiation for Viral Hepatitis (HBV, HCV, and HDV) Through Screening and Diagnosis

Statement of Need

This global discussion among experts in Asia, Europe, and North America focuses on reducing delays in treatment for hepatitis B (HBV), hepatitis C (HCV), and hepatitis D (HDV) by addressing current gaps in screening, including the underuse of evidence-based diagnostic pathways across Asia, Europe, and North America. Current international recommendations and recent regional guideline updates will be reviewed to support practical, scalable improvements in screening and diagnosis to improve patient care. The goal: to translate what we can do into what we consistently do in clinical practice.

This CME Outfitters Snack activity is the first in the four-part series Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum. The series is led by moderators Su Wang, MD (USA) and Heiner Wedemeyer, MD (Germany), with expert discussants Jean-Michel Pawlotsky, MD, PhD (France), Maria Buti, MD, PhD (Spain), George Lau, MD (Hong Kong) and Debika Bhattacharya, MD (USA).

Learning Objectives

At the conclusion of this activity, learners will be able to better:

Interpret the latest global guidelines appropriately for the screening and diagnosis of viral hepatitis infections (HBV, HCV, and HDV) to improve time to treatment initiation from diagnosis

Financial Support

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Target Audience

Global (US, Europe, Asia) physicians, physician associates (PAs), nurse practitioners (NPs), nurses and pharmacists in primary care and specialty settings (focus on ID and hepatology), addiction clinics, reproductive/sexual health clinics, and those HCPs serving vulnerable communities, immigrants, and refugees

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 0.75

CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hours (0.075 CEUs) of continuing pharmacy credit (JA0007185-0000-25-085-H01-P).

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hours.

California Residents: Provider approved by the California Board of Registered Nursing, Provider # CEP 15510, for 0.75 Contact Hours.

Physician Assistants (AAPA) 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 11/21/2026. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.75

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

UEMS-EACCME®

Through a mutual recognition agreement between the AMA and the UEMS-EACCME, European physicians completing an e-learning activity from a US-based ACCME-accredited CME provider can use AMA PRA Category 1 Credit™ toward their credit requirements. CME Outfitters is based in Radnor, Pennsylvania, USA. Please retain your certificate as proof of completion.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Bhattacharya reports the following financial relationships:

Grants: Gilead Sciences, Inc. (grant to institution)

Dr. Buti reports no financial relationships to disclose.

Dr. Lau reports no financial relationships to disclose.

Dr. Pawlotsky reports the following financial relationships:

Advisory Board: Abbott; AbbVie Inc.; Diagnostics for the Real World; and GSK

Speakers Bureau: AbbVie Inc. and Gilead Sciences, Inc.

Dr. Wang reports the following financial relationships:

Research Support: Gilead Sciences, Inc.

Dr. Wedemeyer reports no financial relationships to disclose.

The following individuals have no financial relationships to disclose:

Jeffrey Helfand, DO (Peer Reviewer)
Jessica Giddens, DNP, APRN, FPMHNP-BC, RN-BC (Peer Reviewer)
Mary Gleason, PhD, CHCP (Planning Committee)
Warren Beckman (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

SN-274-112125-47

Improving Time to Treatment Initiation for Viral Hepatitis (HBV, HCV, and HDV) Through Screening and Diagnosis

Faculty

Statement of Need

Learning Objectives

Financial Support

Target Audience